29,841 Shares in Azenta, Inc. (NASDAQ:AZTA) Acquired by Zions Bancorporation National Association UT

Key Points

• Zions Bancorporation National Association UT invested $1.03 million in Azenta, acquiring 29,841 shares, representing approximately 0.07% of the company.
• Azenta reported a $0.19 EPS for the quarter, exceeding analysts' expectations of $0.13, but its revenue of $143.94 million fell short of the forecast of $149.64 million.
• A consensus rating for Azenta is "Hold" with an average target price of $35.75, with various analysts issuing differing ratings and target prices recently.

Zions Bancorporation National Association UT acquired a new position in Azenta, Inc. (NASDAQ:AZTA - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 29,841 shares of the company's stock, valued at approximately $1,034,000. Zions Bancorporation National Association UT owned approximately 0.07% of Azenta at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Mitsubishi UFJ Asset Management Co. Ltd. grew its stake in Azenta by 8.9% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,842 shares of the company's stock worth $168,000 after buying an additional 396 shares during the last quarter. Boothbay Fund Management LLC raised its holdings in shares of Azenta by 8.4% during the fourth quarter. Boothbay Fund Management LLC now owns 6,571 shares of the company's stock worth $329,000 after acquiring an additional 509 shares during the period. Oppenheimer Asset Management Inc. raised its holdings in shares of Azenta by 6.4% during the first quarter. Oppenheimer Asset Management Inc. now owns 12,617 shares of the company's stock worth $437,000 after acquiring an additional 756 shares during the period. Covestor Ltd raised its holdings in shares of Azenta by 64.2% during the fourth quarter. Covestor Ltd now owns 2,043 shares of the company's stock worth $102,000 after acquiring an additional 799 shares during the period. Finally, Sterling Capital Management LLC increased its stake in Azenta by 39.8% in the 4th quarter. Sterling Capital Management LLC now owns 2,856 shares of the company's stock valued at $143,000 after buying an additional 813 shares during the last quarter. 99.08% of the stock is currently owned by institutional investors.

Azenta Stock Performance

Shares of NASDAQ AZTA traded up $1.23 during midday trading on Tuesday, hitting $29.21. 547,206 shares of the company's stock traded hands, compared to its average volume of 732,154. The firm has a fifty day moving average of $31.16 and a 200 day moving average of $33.98. The stock has a market capitalization of $1.34 billion, a price-to-earnings ratio of -12.07 and a beta of 1.59. Azenta, Inc. has a 1 year low of $23.91 and a 1 year high of $55.63.

Azenta (NASDAQ:AZTA - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.13 by $0.06. The company had revenue of $143.94 million during the quarter, compared to the consensus estimate of $149.64 million. Azenta had a positive return on equity of 1.35% and a negative net margin of 18.45%. Azenta's revenue was up .0% on a year-over-year basis. During the same period last year, the company earned $0.14 earnings per share. On average, equities analysts anticipate that Azenta, Inc. will post 0.53 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts recently commented on the stock. Needham & Company LLC reduced their target price on shares of Azenta from $59.00 to $40.00 and set a "buy" rating for the company in a report on Wednesday, May 7th. Stephens began coverage on shares of Azenta in a research report on Tuesday, July 22nd. They issued an "equal weight" rating and a $35.00 price target for the company. Evercore ISI set a $33.00 price objective on shares of Azenta and gave the company an "in-line" rating in a research note on Tuesday, August 5th. Finally, Raymond James Financial raised shares of Azenta from a "market perform" rating to an "outperform" rating and set a $35.00 target price on the stock in a research note on Wednesday, August 6th. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $35.75.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.